Scholarlink

The immunogeneity of polyethylene glycol (PEG) present in commercial lipid nanoparticles for mRNA delivery has accelerated the development of less immunogenic alternatives.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

PEG alternatives for RNA therapeutics

  • 专题合集

  • 发表日期：

    2025年

查看全文

摘要

The immunogeneity of polyethylene glycol (PEG) present in commercial lipid nanoparticles for mRNA delivery has accelerated the development of less immunogenic alternatives.